YOU ARE HERE:
Latin America news
page  of 5
 
Headline
Date
  Some HIV subtypes may carry natural resistance to tipranavir
20.03.08
  'Brazilian model' saves over $1 billion in anti-HIV treatment costs
20.11.07
  IAS: Roche admits long-standing low-level contamination of nelfinavir
26.07.07
  IAS: Regular dietician consultation effective at preventing HAART-associated dyslipidaemia
25.07.07
  IAS: Cardiovascular disease and diabetes increasing as causes of death for people with HIV in Brazil
25.07.07
  Brazil: Kaletra price cut agreed as generic efavirenz arrives
05.07.07
  Half of all new HIV infections could be averted if proven prevention efforts expanded
29.06.07
  Roche agrees to temporary suspension of nelfinavir's (Viracept) European license - updated
21.06.07
  Near-global nelfinavir (Viracept) recall 'very difficult situation'
20.06.07
  WHO/UNAIDS endorse opt-out HIV testing
30.05.07
  Boehringer cuts nevirapine price for developing world
15.05.07
  Brazil issues compulsory license on efavirenz
07.05.07
  Brazil demands 60% efavirenz price cut, or may break patent
26.04.07
  Leprosy reported after starting HIV treatment, but it isn't a serious public health concern
08.02.07
  Non UK-born migrants are 'largely hidden' from NHS and have high burden of HIV, TB and malaria
16.11.06
  Brazil begins negotiations over Kaletra price again
07.11.06
  New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis
03.11.06
  Fast, accurate and easy TB test developed, but concerns about its safety raised
12.10.06
  Alphabet of prevention technologies expanding, but no 'magical solution'
23.08.06
  Lowered AZT dose for low weight patients 'effective and reduces toxicity'
10.08.06

page  of 5